Restricted accessLetterFirst published online 2024-2
Comment on: Drugs That Interact With Colchicine via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)
Gómez-LumbrerasABoyceRDVilla-ZapataL, et al. Drugs that interact with colchicine via inhibition of cytochrome P450 3A4 and p-glycoprotein: a signal detection analysis using a database of spontaneously reported adverse events (FAERS). Ann Pharmacother. 2023;23:10600280221148031.
2.
NoguchiYTachiTTeramachiH. Comparison of signal detection algorithms based on frequency statistical model for drug-drug interaction using spontaneous reporting systems. Pharm Res. 2020;37:86.
3.
NoguchiYTachiTTeramachiH. Subset analysis for screening drug-drug interaction signal using pharmacovigilance database. Pharmaceutics. 2020;12:762.
4.
NoguchiYYoshizawaSAoyamaKKuboSTachiTTeramachiH. Verification of the “Upward variation in the reporting odds ratio scores” to detect the signals of drug-drug interactions. Pharmaceutics. 2021;13:1531.
5.
FujitaT. Signal detection of adverse drug reactions. Jpn J Pharmacoepidemiol. 2009;14:27-36.
6.
UrushiharaH. Basic dos and don’ts in applying signal detection methods to spontaneous reporting systems databases. Jpn J Drug Inform. 2019;21:135-141.
7.
NorénGNHopstadiusJBateA. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. 2013;22(1):57-69.
8.
NoguchiYTachiTTeramachiH. Review of statistical methodologies for detecting drug-drug interactions using spontaneous reporting systems. Front Pharmacol. 2019;10:1319.
9.
NoguchiYTachiTTeramachiH. Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief Bioinform. 2021;22:bbab347.
